4.7 Article

Human adventitial pericytes provide a unique source of anti-calcific cells for cardiac valve engineering: Role of microRNA-132-3p

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 165, Issue -, Pages 137-151

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2021.01.029

Keywords

Valvular heart disease; Prosthetic valve; Calcification; Tissue engineering; Pericytes; Mesenchymal stromal cells; microRNAs

Funding

  1. British Heart Foundation (BHF) Centre for Cardiovascular Regenerative Medicine Award (II)-Centre for Vascular Regeneration [RM/17/3/33381]
  2. BHF [PG/15/95/31853, PG/18/38/33707]
  3. Heart Research UK (HRUK) [RG2656/17/20]
  4. NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust
  5. University of Bristol

Ask authors/readers for more resources

This study demonstrates that human adventitial pericytes (APCs) exhibit resistance to calcification compared to bone marrow-derived mesenchymal stromal cells (BM-MSCs) and convey the anti-calcific phenotype to heart valves through miR-132. These findings suggest that APCs may be a promising cell source for cellularization of prosthetic heart valves.
Aims: Tissue engineering aims to improve the longevity of prosthetic heart valves. However, the optimal cell source has yet to be determined. This study aimed to establish a mechanistic rationale supporting the suitability of human adventitial pericytes (APCs). Methods and results: APCs were immunomagnetically sorted from saphenous vein leftovers of patients undergoing coronary artery bypass graft surgery and antigenically characterized for purity. Unlike bone marrow-derived mesenchymal stromal cells (BM-MSCs), APCs were resistant to calcification and delayed osteochondrogenic differentiation upon high phosphate (HP) induction, as assessed by cytochemistry and expression of osteogenic markers. Moreover, glycolysis was activated during osteogenic differentiation of BM-MSCs, whereas APCs showed no increase in glycolysis upon HP challenge. The microRNA-132-3p (miR-132), a known inhibitor of osteogenesis, was found constitutively expressed by APCs and upregulated following HP stimulation. The anti-calcific role of miR-132 was further corroborated by in silico analysis, luciferase assays in HEK293 cells, and transfecting APCs with miR-132 agomir and antagomir, followed by assessment of osteochondrogenic markers. Interestingly, treatment of swine cardiac valves with APC-derived conditioned medium conferred them with resistance to HP-induced osteogenesis, with this effect being negated when using the medium of miR-132-silenced APCs. Additionally, as an initial bioengineering step, APCs were successfully engrafted onto pericar-dium sheets, where they proliferated and promoted aortic endothelial cells attraction, a process mimicking valve endothelialization. Conclusions: Human APCs are resistant to calcification compared with BM-MSCs and convey the anti-calcific phenotype to heart valves through miR-132. These findings may open new important avenues for prosthetic valve cellularization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available